Methods and Compositions for Preventing Metastasis and for Improving the Survival Time

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160030367A1
SERIAL NO

14775208

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to an AMPK activator (such as for instance metformin) for use in preventing metastasis in a patient suffering from a cancer, wherein said patient has a non-mutated p53 gene or lacks a mutant form of the p53 protein. The invention also relates to an AMPK activator for use in improving the survival time of a patient suffering from a cancer, wherein said patient has a non-mutated p53 gene or lacks a mutant form of the p53 protein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS F-75013
UNIVERSITE NICE SOPHIA ANTIPOLIS28 AVENUE VALROSE NICE F-06103

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ballotti, Robert Nice Cedex 3, FR 13 8
Cerezo, Michael Nice Cedex 3, FR 2 1
Rocchi, Stephane Nice Cedex 3, FR 6 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation